XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
The Company, Business Activities and Basis of Presentation (Tables)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Composition of Net Revenues Recognized Disaggregated by Source and Nature

The composition of the Company’s net revenues recognized during the three and nine months ended September 30, 2017 and 2018, disaggregated by source and nature, are as follows:

 

 

For the three months ended September 30,

 

 

For the nine months ended September 30,

 

 

2017

 

 

2018

 

 

2017

 

 

2018

 

Net revenues from contracted payers*

$

422,136

 

 

$

325,097

 

 

$

1,655,287

 

 

$

1,019,857

 

Net revenues from non-contracted payers

 

621,881

 

 

 

373,018

 

 

 

2,206,414

 

 

 

1,211,309

 

Development services revenues

 

67,394

 

 

 

63,476

 

 

 

211,736

 

 

 

159,606

 

Total net revenues

$

1,111,411

 

 

$

761,591

 

 

$

4,073,437

 

 

$

2,390,772

 

 

*Includes Medicare and Medicare Advantage, as reimbursement amounts are fixed and miscellaneous income from CEE-Sure blood collection tubes.

 

 

For the three months ended September 30,

 

 

For the nine months ended September 30,

 

 

2017

 

 

2018

 

 

2017

 

 

2018

 

Net commercial revenues recognized upon delivery

$

941,783

 

 

$

698,115

 

 

$

2,703,424

 

 

$

2,231,166

 

Development services revenues recognized upon delivery

 

67,394

 

 

 

63,476

 

 

 

211,736

 

 

 

159,606

 

Commercial revenues recognized upon cash collection

 

102,234

 

 

 

 

 

 

1,158,277

 

 

 

 

Total net revenues

$

1,111,411

 

 

$

761,591

 

 

$

4,073,437

 

 

$

2,390,772

 

 

Summary of Third-Party Payers That Represent More Than 10% of Total Net Revenues and Total Net Accounts Receivable and Their Related Percentage

The Company's third-party payers that represent more than 10% of total net revenues in any period presented, as well as their related net revenue amount as a percentage of total net revenues, during the three and nine months ended September 30, 2017 and 2018 were as follows:

 

 

For the three months ended September 30,

 

 

For the nine months ended September 30,

 

 

2017

 

 

2018

 

 

2017

 

 

2018

 

Medicare and Medicare Advantage

 

45

%

 

 

40

%

 

 

41

%

 

 

39

%

Blue Cross Blue Shield

 

16

%

 

 

9

%

 

 

17

%

 

 

14

%

United Healthcare

 

14

%

 

 

6

%

 

 

12

%

 

 

15

%

The Company's third-party payers that represent more than 10% of total net accounts receivable, and their related net accounts receivable balance as a percentage of total net accounts receivable, at December 31, 2017 and September 30, 2018 were as follows:

 

 

December 31, 2017

 

 

September 30, 2018

 

Blue Cross Blue Shield

 

27

%

 

 

22

%

Medicare and Medicare Advantage

 

21

%

 

 

18

%

United Healthcare

 

15

%

 

 

11

%